ANI PHARMACEUTICALS, INC Operating Lease, Weighted Average Discount Rate, Percent
ANI PHARMACEUTICALS, INC (ANIP) had Operating Lease, Weighted Average Discount Rate, Percent of 7.74% as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-02-27
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 7.74%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 8.10%.
- 2023-12-31: Operating Lease, Weighted Average Discount Rate, Percent 8.12%.
- 2022-12-31: Operating Lease, Weighted Average Discount Rate, Percent 3.99%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-12-31 | 7.74% 10-K · filed 2026-02-27 |
| 2024-12-31 | 8.10% 10-K · filed 2026-02-27 |
| 2023-12-31 | 8.12% 10-K · filed 2025-02-28 |
| 2022-12-31 | 3.99% 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |